20 June 2013
Keywords: antizol, cleared, uk, orphan, medical, received, approval
Article | 01 July 1999
Orphan Medical has received approval from the UK Medicines ControlAgency to market Antizol (fomepizole) as an antidote for suspected or
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
19 June 2013
© 2013 thepharmaletter.com